Birdshot Chorioretinopathy treated with dexamethasone intravitreal implant and a biologic response modifier: a successful management
Revista de Medicina da UFC
Endereço:
Gerência de Ensino e Pesquisa - Universidade Federal do Ceará/Rua Coronel Nunes de Melo, S/N - Bloco dos ambulatórios (ilhas) - Andar superior - Rodolfo Teófilo
Fortaleza / CE
60430-270
Site: http://periodicos.ufc.br/revistademedicinadaufc
Telefone: (85) 3366-8590
ISSN: 24476595
Editor Chefe: Renan Magalhães Montenegro Júnior
Início Publicação: 30/11/2014
Periodicidade: Trimestral
Área de Estudo: Medicina
Birdshot Chorioretinopathy treated with dexamethasone intravitreal implant and a biologic response modifier: a successful management
Ano: 2017 | Volume: 57 | Número: 3
Autores: Ricardo Evangelista Marrocos de Aragao, Ieda Maria Alexandre Barreira, Cristina Muccioli, Francisco Holanda Oliveira Neto, Barbara Lorena Alves Arrais, Francisco George Magalhães de Oliveira, Gustavo Jose Arruda Mendes Carneiro
Autor Correspondente: Ricardo Evangelista Marrocos de Aragao | [email protected]
Autor Correspondente: Ricardo Evangelista Marrocos de Aragao | [email protected]
Palavras-chave: uveitis, birdshot chorioretinopathy, HLA-A29, retinal vasculitis, anti-inflammatory agents.
Resumos Cadastrados
Resumo Inglês:
Birdshot chorioretinopathy is an organ-specific, potentially blinding chronic of bilateral inflammation of the posterior eye segment. It is seen mainly in persons who have the HLA-A29 haplotype. The diagnosis remains clinical and is based in his hallmark, which is the presence of multiples white dots throughout the fundus, resembling a shotgun pattern. The immune mechanisms involved in its pathogenesis remains unclear and the long-term outcome is guarded. However, the use of immunosuppressive agents and newer therapies demonstrated control of the inflammation and is a hope mainly in refractory cases. We report a case of Birdshot chorioretinopathy treated successfully with steroids and immunosuppressive agents.
